What Happened?
Woburn, MA-based Curie Therapeutics Appointed Bernard Lambert as Chief Technology Officer
About the Company
Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie`s radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads. Curie`s mission is to revolutionize the use of radiomedicines in cancer.
About the Person
Bernard Lambert is Chief Technology Officer at Curie Therapeutics. Previously, Bernard held various senior IT leadership roles in the industry.
Info Source
News
Short Profile